Försti A - Search Results

1

The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.

Weinhold N, Johnson DC, Chubb D, Chen B, Försti A, Hosking FJ, Broderick P, Ma YP, Dobbins SE, Hose D, Walker BA, Davies FE, Kaiser MF, Li NL, Gregory WA, Jackson GH, Witzens-Harig M, Neben K, Hoffmann P, Nöthen MM, Mühleisen TW, Eisele L, Ross FM, Jauch A, Goldschmidt H, Houlston RS, Morgan GJ, Hemminki K. Weinhold N, et al. Among authors: forsti a. Nat Genet. 2013 May;45(5):522-525. doi: 10.1038/ng.2583. Epub 2013 Mar 17. Nat Genet. 2013. PMID: 23502783 Free PMC article.

2

Unique properties of cisplatin in reactions with nucleophiles.

Försti A, Hemminki K. Försti A, et al. IARC Sci Publ. 1986;(78):101-10. IARC Sci Publ. 1986. PMID: 3583384 No abstract available.

3

A 32P-postlabelling assay for DNA adducts induced by cis-diamminedichloroplatinum(II).

Försti A, Hemminki K. Försti A, et al. Cancer Lett. 1994 Aug 15;83(1-2):129-37. doi: 10.1016/0304-3835(94)90309-3. Cancer Lett. 1994. PMID: 8062205

4

Use of twins in search for tumor suppressor genes.

Försti A, Söderberg M, Hemminki K. Försti A, et al. Environ Mol Mutagen. 1997;30(2):231-9. doi: 10.1002/(sici)1098-2280(1997)30:2<231::aid-em16>3.0.co;2-e. Environ Mol Mutagen. 1997. PMID: 9329648

5

DNA copy number losses at 1p32-pter in monozygotic twins concordant for breast cancer.

el-Rifai W, Tarmo L, Hemmer S, Försti A, Pedersen N, Lichtenstein P, Ahlbom A, Söderberg M, Knuutila S, Hemminki K. el-Rifai W, et al. Among authors: forsti a. Cancer Genet Cytogenet. 1999 Jul 15;112(2):169-72. doi: 10.1016/s0165-4608(98)00274-x. Cancer Genet Cytogenet. 1999. PMID: 10686947

6

Single nucleotide polymorphism analyses of the human proliferating cell nuclear antigen (pCNA) and flap endonuclease (FEN1) genes.

Ma X, Jin Q, Försti A, Hemminki K, Kumar R. Ma X, et al. Among authors: forsti a. Int J Cancer. 2000 Dec 15;88(6):938-42. doi: 10.1002/1097-0215(20001215)88:6<938::aid-ijc16>3.0.co;2-g. Int J Cancer. 2000. PMID: 11093818 Free article.

7

Proper controls for SNP studies?

Hemminki K, Försti A. Hemminki K, et al. Among authors: forsti a. Carcinogenesis. 2002 Aug;23(8):1405. doi: 10.1093/carcin/23.8.1405. Carcinogenesis. 2002. PMID: 12151361 No abstract available.

8

Single nucleotide polymorphisms in the XPG gene: determination of role in DNA repair and breast cancer risk.

Kumar R, Höglund L, Zhao C, Försti A, Snellman E, Hemminki K. Kumar R, et al. Among authors: forsti a. Int J Cancer. 2003 Feb 20;103(5):671-5. doi: 10.1002/ijc.10870. Int J Cancer. 2003. PMID: 12494477 Free article.

9

Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: no association.

Försti A, Zhao C, Israelsson E, Dahlman-Wright K, Gustafsson JA, Hemminki K. Försti A, et al. Breast Cancer Res Treat. 2003 Jun;79(3):409-13. doi: 10.1023/a:1024020609833. Breast Cancer Res Treat. 2003. PMID: 12846425

10

Single nucleotide polymorphisms in breast cancer.

Försti A, Angelini S, Festa F, Sanyal S, Zhang Z, Grzybowska E, Pamula J, Pekala W, Zientek H, Hemminki K, Kumar R. Försti A, et al. Oncol Rep. 2004 Apr;11(4):917-22. Oncol Rep. 2004. PMID: 15010895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

414 results

Search Page